NCT04777851 2026-03-09
REPLACE
Translational Research in Oncology
Phase 3 Terminated
Clinical Trials
5 trialsNCT03829462 2025-11-21
NEXT-REGIRI
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 3 Active not recruiting
NCT02934529 2025-04-16
AIO-KRK-0114
Ludwig-Maximilians - University of Munich
Phase 3 Completed
NCT05794971 2023-05-15
RIDER
Sun Yat-sen University
Phase 3 Recruiting
NCT01786538 2013-03-13
Second-line FOLFOX With or Without Regorafenib in mCRC Patients Failed to First-line Irinotecan Plus Fluoropyrimidines
Asan Medical Center
Phase 3 Withdrawn